PATH-SS for PTSD and Depression after Sexual Assault
This study is testing a new, brief talk therapy called Positive Processes and Transition to Health - Single-Session (PATH-SS). It aims to help people aged 18-65 in Ohio who have experienced a sexual assault within the last 5 years and are struggling with symptoms of PTSD (Post-Traumatic Stress Disorder) or depression. The researchers want to see if PATH-SS can reduce these symptoms and if participants find the therapy helpful. The study plans to enroll 45 participants and is currently unclear on its recruitment status.
- Study design
- This is an open trial (meaning both participants and researchers know what treatment is being given) for 45 adults. It is an interventional study, meaning participants will receive a specific treatment.
- What's involved
- You would attend a pre-treatment assessment, one 2-hour PATH-SS therapy session, and then two follow-up assessments, each lasting about 1 hour, over a 1-month period.
- Compensation
- You will receive a $20 Amazon or Visa gift card for each assessment completed after the treatment session.
- Follow-up
- Your symptoms will be assessed at 1 month after completing the treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Positive Processes and Transition to Health - Single-Session (PATH-SS)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Norah C Feeny, PhD · PRINCIPAL_INVESTIGATOR · Case Western Reserve University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- PTSD Symptom Scale-Interview (PSS-I-5; Foa et al., 2016)From baseline to follow-up at 1 month after treatment completion
The PSS-I is a 24-item, state-of-the-art, psychometrically-validated interview used to assess DSM-5 criteria for PTSD and symptom severity. The PSS-I-5 includes 20 questions assessing symptom severity on a 5-point Likert scale (0 = not at all, 4 = six or more times a week/severe), and scores are calculated by summing responses, with higher scores indicating higher PTSD severity, as well as two questions assessing distress and interference and two questions assessing symptom onset and duration.
- Quick Inventory of Depressive Symptomatology-Clinican Report (QIDS-C; Rush et al., 2003)From baseline to follow-up at 1 month after treatment completion
The QIDS-C is a 16 item, state-of-the-art, psychometrically-validated interview used to assess depression. Items are rated on a 4-point scale with anchors that vary with the question (e.g., 0 = I do not feel sad, 3 = I feel sad nearly all of the time).
- Post-traumatic Stress Diagnostic Scale (PDS-5; Foa et al., 2016)From baseline to follow-up at 1 month after treatment completion
The PDS-5 is a 24-item self-report measure used to assess prior trauma exposure and subsequent PTSD symptoms in the past month. The PDS-5 uses a trauma screen to identify prior exposure to traumatic events and assesses the severity of DSM-5 PTSD symptoms related to the event causing the most distress. The PDS-5 includes 20 questions assessing symptom severity on a 5-point Likert scale (0 = not at all, 4 = six or more times a week/severe), and scores are calculated by summing responses, with higher scores indicating higher PTSD severity. The PDS-5 also includes two questions assessing distress and interference and two questions assessing symptom onset and duration.
- Quick Inventory of Depressive Symptomatology Self-Report Version (QIDS-SR; Rush et al., 2003)From baseline to follow-up at 1 month after treatment completion
The QIDS-SR is a 16-item self-report measure that assesses depression. Items are rated on a 4-point scale with anchors that vary with the question (e.g., 0 = I do not feel sad, 3 = I feel sad nearly all of the time).